These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 9420017)
1. Perspectives on new chemotherapeutic agents in the treatment of colorectal cancer. Clark JW Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-19-S18-24. PubMed ID: 9420017 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of colorectal cancer: history and new themes. Bertino JR Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-3-S18-7. PubMed ID: 9420015 [TBL] [Abstract][Full Text] [Related]
3. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status. Papamichael D Oncologist; 1999; 4(6):478-87. PubMed ID: 10631692 [TBL] [Abstract][Full Text] [Related]
4. Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancer. Makower D; Wadler S Semin Oncol; 1999 Dec; 26(6):663-71. PubMed ID: 10606259 [TBL] [Abstract][Full Text] [Related]
5. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status. Papamichael D Stem Cells; 2000; 18(3):166-75. PubMed ID: 10840069 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer]. Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867 [TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin for the treatment of advanced colorectal cancer: future directions. Ducreux M; Louvet C; Bekradda M; Cvitkovic E Semin Oncol; 1998 Apr; 25(2 Suppl 5):47-53. PubMed ID: 9609108 [TBL] [Abstract][Full Text] [Related]
8. Perspectives in the treatment of colorectal cancer. Ozer H; Diasio RB Semin Oncol; 2004 Dec; 31(6 Suppl 15):14-8. PubMed ID: 15726534 [TBL] [Abstract][Full Text] [Related]
9. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma]. Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407 [TBL] [Abstract][Full Text] [Related]
10. Biomodulation of 5-fluorouracil with antifolates. Bertino JR Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-52-S18-56. PubMed ID: 9420021 [TBL] [Abstract][Full Text] [Related]
11. New concepts for the development and use of antifolates. Chu E; Grem JL; Johnston PG; Allegra CJ Stem Cells; 1996 Jan; 14(1):41-6. PubMed ID: 8820950 [TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin in the treatment of colorectal cancer. Kim GP; Erlichman C Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):281-94. PubMed ID: 17428157 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy. Yamada H; Iinuma H; Watanabe T Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408 [TBL] [Abstract][Full Text] [Related]
14. The medical treatment of colorectal cancer: actual status and new developments. Van Cutsem E; Peeters M; Verslype C; Filez L; Haustermans K; Janssens J Hepatogastroenterology; 1999; 46(26):709-16. PubMed ID: 10370599 [TBL] [Abstract][Full Text] [Related]
15. [5-fluorouracil]. Aiba K Gan To Kagaku Ryoho; 2001 Oct; 28(10):1368-79. PubMed ID: 11681244 [TBL] [Abstract][Full Text] [Related]